Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 246

1.

Complement therapy in atypical haemolytic uraemic syndrome (aHUS).

Wong EK, Goodship TH, Kavanagh D.

Mol Immunol. 2013 Dec 15;56(3):199-212. doi: 10.1016/j.molimm.2013.05.224. Epub 2013 Jun 28. Review.

2.

Haemolytic uraemic syndrome.

Kavanagh D, Goodship T.

Nephron Clin Pract. 2011;118(1):c37-42. doi: 10.1159/000320901. Epub 2010 Nov 11.

PMID:
21071971
3.

[Atypical hemolytic-uremic syndrome related to abnormalities within the complement system].

Frémeaux-Bacchi V, Fakhouri F, Roumenina L, Dragon-Durey MA, Loirat C.

Rev Med Interne. 2011 Apr;32(4):232-40. doi: 10.1016/j.revmed.2009.09.039. Epub 2011 Mar 3. French.

4.

A new era in the diagnosis and treatment of atypical haemolytic uraemic syndrome.

Westra D, Wetzels JF, Volokhina EB, van den Heuvel LP, van de Kar NC.

Neth J Med. 2012 Apr;70(3):121-9. Review.

5.

Atypical hemolytic uremic syndrome.

Kavanagh D, Goodship TH.

Curr Opin Hematol. 2010 Sep;17(5):432-8. doi: 10.1097/MOH.0b013e32833cae86. Review.

PMID:
20613506
6.

Clinical practice guidelines for the management of atypical haemolytic uraemic syndrome in the United Kingdom.

Taylor CM, Machin S, Wigmore SJ, Goodship TH; working party from the Renal Association, the British Committee for Standards in Haematology and the British Transplantation Society.

Br J Haematol. 2010 Jan;148(1):37-47. doi: 10.1111/j.1365-2141.2009.07916.x. Epub 2009 Oct 11.

7.

An update for atypical haemolytic uraemic syndrome: diagnosis and treatment. A consensus document.

Campistol JM, Arias M, Ariceta G, Blasco M, Espinosa L, Espinosa M, Grinyó JM, Macía M, Mendizábal S, Praga M, Román E, Torra R, Valdés F, Vilalta R, Rodríguez de Córdoba S.

Nefrologia. 2015;35(5):421-47. doi: 10.1016/j.nefro.2015.07.005. Epub 2015 Oct 9. English, Spanish.

8.

Complement disorders and hemolytic uremic syndrome.

Joseph C, Gattineni J.

Curr Opin Pediatr. 2013 Apr;25(2):209-15. doi: 10.1097/MOP.0b013e32835df48a. Review.

9.

Atypical Hemolytic Uremic Syndrome: A Meta-Analysis of Case Reports Confirms the Prevalence of Genetic Mutations and the Shift of Treatment Regimens.

Krishnappa V, Gupta M, Elrifai M, Moftakhar B, Ensley MJ, Vachharajani TJ, Sethi SK, Raina R.

Ther Apher Dial. 2018 Apr;22(2):178-188. doi: 10.1111/1744-9987.12641. Epub 2017 Dec 17.

PMID:
29250893
10.

Transplantation in atypical hemolytic uremic syndrome.

Kavanagh D, Richards A, Goodship T, Jalanko H.

Semin Thromb Hemost. 2010 Sep;36(6):653-9. doi: 10.1055/s-0030-1262887. Epub 2010 Sep 23. Review.

PMID:
20865642
11.

Eculizumab therapy for atypical haemolytic uraemic syndrome due to a gain-of-function mutation of complement factor B.

Gilbert RD, Fowler DJ, Angus E, Hardy SA, Stanley L, Goodship TH.

Pediatr Nephrol. 2013 Aug;28(8):1315-8. doi: 10.1007/s00467-013-2492-x. Epub 2013 Apr 28.

PMID:
23624872
12.

Eculizumab in anti-factor h antibodies associated with atypical hemolytic uremic syndrome.

Diamante Chiodini B, Davin JC, Corazza F, Khaldi K, Dahan K, Ismaili K, Adams B.

Pediatrics. 2014 Jun;133(6):e1764-8. doi: 10.1542/peds.2013-1594.

PMID:
24843055
13.

Eculizumab in atypical hemolytic uremic syndrome: long-term clinical course and histological findings.

Tschumi S, Gugger M, Bucher BS, Riedl M, Simonetti GD.

Pediatr Nephrol. 2011 Nov;26(11):2085-8. doi: 10.1007/s00467-011-1989-4. Epub 2011 Aug 30.

14.

aHUS caused by complement dysregulation: new therapies on the horizon.

Waters AM, Licht C.

Pediatr Nephrol. 2011 Jan;26(1):41-57. doi: 10.1007/s00467-010-1556-4. Epub 2010 Jun 18. Review. Erratum in: Pediatr Nephrol. 2013 Jan;28(1):165.

15.

Atypical hemolytic uremic syndrome.

Kavanagh D, Goodship TH, Richards A.

Semin Nephrol. 2013 Nov;33(6):508-30. doi: 10.1016/j.semnephrol.2013.08.003. Review.

16.

Rapid recovery of membrane cofactor protein (MCP; CD46) associated atypical haemolytic uraemic syndrome with plasma exchange.

Reid VL, Mullan A, Erwig LP.

BMJ Case Rep. 2013 Sep 4;2013. pii: bcr2013200980. doi: 10.1136/bcr-2013-200980.

17.

An unusual case of haemolytic uraemic syndrome following endoscopic retrograde cholangiopancreatography rapidly improved with eculizumab.

Taton O, Delhaye M, Stordeur P, Goodship T, Le Moine A, Massart A.

Acta Gastroenterol Belg. 2016 Apr-Jun;79(2):257-61.

PMID:
27382949
18.

How I treat thrombotic thrombocytopenic purpura and atypical haemolytic uraemic syndrome.

Scully M, Goodship T.

Br J Haematol. 2014 Mar;164(6):759-66. doi: 10.1111/bjh.12718. Epub 2014 Jan 6. Review.

19.

Atypical hemolytic uremic syndrome: from the rediscovery of complement to targeted therapy.

Fakhouri F, Frémeaux-Bacchi V, Loirat C.

Eur J Intern Med. 2013 Sep;24(6):492-5. doi: 10.1016/j.ejim.2013.05.008. Epub 2013 Jun 5. Review.

PMID:
23756030
20.

Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies.

Zuber J, Fakhouri F, Roumenina LT, Loirat C, Frémeaux-Bacchi V; French Study Group for aHUS/C3G.

Nat Rev Nephrol. 2012 Nov;8(11):643-57. doi: 10.1038/nrneph.2012.214. Epub 2012 Oct 2. Review.

PMID:
23026949

Supplemental Content

Support Center